Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | HRTX | Common Stock | Other | $5.78K | +1.5K | +13.83% | $3.84 | 12.4K | Apr 29, 2022 | Direct | F1 |
transaction | HRTX | Common Stock | Sale | -$7.15K | -1.5K | -12.15% | $4.76 | 10.9K | May 3, 2022 | Direct | F2, F3 |
Id | Content |
---|---|
F1 | Represents shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 29, 2022. |
F2 | The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of September 13, 2021. |
F3 | The range of sales prices received was $4.695 to $4.835. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price. |